Secondary Cancers Post CAR T Therapy: A Concern? Secondary Cancers Post CAR T Therapy: A Concern?

An analysis of the FAERS database found the incidence of secondary cancers following CAR T therapy represented 4.3% of all adverse events; however, only 0.1% were secondary T-cell malignancies.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Hematology-Oncology Source Type: news